Biotech Values

[pharmaclown35]

Yeah I know. I like him. He definately knows what he is doing. I know, I think MS will be a big blowout year for BIIB. I'm really excited to see how BG-12's launch trajectory looks like.

On GSK's breakout at JPM, I was surprised to hear that they are planning to do nothing new to marketing strategy for Benlysta. Oh well.